tiprankstipranks
Advertisement
Advertisement
Quest Diagnostics price target raised to $229 from $224 at Baird
PremiumThe FlyQuest Diagnostics price target raised to $229 from $224 at Baird
1M ago
Quest Diagnostics price target raised to $245 from $225 at BofA
Premium
The Fly
Quest Diagnostics price target raised to $245 from $225 at BofA
1M ago
Quest Diagnostics price target raised to $230 from $225 at Barclays
Premium
The Fly
Quest Diagnostics price target raised to $230 from $225 at Barclays
1M ago
Early notable gainers among liquid option names on April 21st
PremiumThe FlyEarly notable gainers among liquid option names on April 21st
1M ago
Quest Diagnostics: Sustained Volume Growth and Upgraded Revenue Outlook Justify Premium Valuation and Buy Rating
Premium
Ratings
Quest Diagnostics: Sustained Volume Growth and Upgraded Revenue Outlook Justify Premium Valuation and Buy Rating
1M ago
Quest Diagnostices reports Q1 adjusted EPS $2.50, consensus $2.37
Premium
The Fly
Quest Diagnostices reports Q1 adjusted EPS $2.50, consensus $2.37
1M ago
The Week That Was, The Week Ahead: Macro and Markets, April 5
PremiumMarket NewsThe Week That Was, The Week Ahead: Macro and Markets, April 5
2M ago
Quest Diagnostics Adds Veteran Healthcare Leader to Board
Premium
Company Announcements
Quest Diagnostics Adds Veteran Healthcare Leader to Board
2M ago
Quest Diagnostics elects Timothy Wentworth to Board of Directors
Premium
The Fly
Quest Diagnostics elects Timothy Wentworth to Board of Directors
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100